Prothena Corp PLC (PRTA)
21.17
+0.60
(+2.92%)
USD |
NASDAQ |
Apr 19, 16:00
21.17
0.00 (0.00%)
After-Hours: 16:20
Prothena Cash and Short Term Investments (Quarterly): 618.83M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 618.83M |
| September 30, 2023 | 670.90M |
| June 30, 2023 | 659.11M |
| March 31, 2023 | 686.18M |
| December 31, 2022 | 710.41M |
| September 30, 2022 | 495.63M |
| June 30, 2022 | 508.80M |
| March 31, 2022 | 542.99M |
| December 31, 2021 | 579.09M |
| September 30, 2021 | 600.10M |
| June 30, 2021 | 399.83M |
| March 31, 2021 | 342.99M |
| December 31, 2020 | 295.38M |
| September 30, 2020 | 314.52M |
| June 30, 2020 | 333.94M |
| March 31, 2020 | 352.68M |
| December 31, 2019 | 375.72M |
| September 30, 2019 | 390.30M |
| June 30, 2019 | 398.14M |
| March 31, 2019 | 410.11M |
| December 31, 2018 | 427.66M |
| September 30, 2018 | 451.51M |
| June 30, 2018 | 486.21M |
| Date | Value |
|---|---|
| March 31, 2018 | 429.04M |
| December 31, 2017 | 417.62M |
| September 30, 2017 | 456.06M |
| June 30, 2017 | 471.73M |
| March 31, 2017 | 506.55M |
| December 31, 2016 | 386.92M |
| September 30, 2016 | 408.57M |
| June 30, 2016 | 442.95M |
| March 31, 2016 | 474.25M |
| December 31, 2015 | 370.59M |
| September 30, 2015 | 387.80M |
| June 30, 2015 | 402.39M |
| March 31, 2015 | 279.86M |
| December 31, 2014 | 293.58M |
| September 30, 2014 | 306.15M |
| June 30, 2014 | 303.85M |
| March 31, 2014 | 195.05M |
| December 31, 2013 | 176.68M |
| September 30, 2013 | 101.86M |
| June 30, 2013 | 112.51M |
| March 31, 2013 | 119.56M |
| December 31, 2012 | 124.86M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
295.38M
Minimum
Dec 2020
710.41M
Maximum
Dec 2022
488.19M
Average
495.63M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Amarin Corp PLC | 320.66M |
| Jazz Pharmaceuticals PLC | 1.626B |
| Iterum Therapeutics PLC | 23.93M |
| GH Research PLC | 161.56M |
| Mural Oncology PLC | 270.85M |